Erica Schwartz

News

Former Deputy Surgeon General Erica Schwartz could end months at the CDC without Senate-confirmed leadership if she becomes Director.

News

Ibrance has become the first CDK4/6 inhibitor to be approved for a challenging subtype of breast cancer that is often resistant to current treatment.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.